Prab: CSV import

2025-03-17T19:39:37Z

CSV import

← Older revision		Revision as of 19:39, 17 March 2025
Line 28:		Line 28:
	{{medicine-stub}}		{{medicine-stub}}
	{{No image}}		{{No image}}
			__NOINDEX__

Prab: CSV import

2025-02-11T03:48:06Z

CSV import

← Older revision		Revision as of 03:48, 11 February 2025
Line 27:		Line 27:

	{{medicine-stub}}		{{medicine-stub}}
			{{No image}}

Prab: CSV import

2024-03-30T22:11:21Z

CSV import

New page

'''Multicenter AIDS Cohort Study (MACS)''' is a long-term [[clinical study]] initiated in 1984 to investigate the natural and treated histories of the [[Human Immunodeficiency Virus (HIV)]] and [[Acquired Immunodeficiency Syndrome (AIDS)]]. The study is one of the most comprehensive efforts to understand the progression of HIV/AIDS in the [[United States]], focusing on the epidemiology, virology, immunology, and pathology of the disease. The MACS has significantly contributed to the understanding of HIV/AIDS, influencing both clinical practice and public health policies.

==Background==
The Multicenter AIDS Cohort Study was established in response to the growing HIV/AIDS epidemic in the early 1980s. It was designed to follow the natural history of untreated HIV infection and the effects of treatment in a cohort of [[homosexual]] and [[bisexual]] men, a group at high risk for HIV infection. The study was initially funded by the [[National Institute of Allergy and Infectious Diseases]] (NIAID), part of the [[National Institutes of Health]] (NIH), and has since received support from various other NIH institutes.

==Study Design==
The MACS is a prospective cohort study that has enrolled over 7,000 men who have sex with men (MSM) from four metropolitan areas in the United States: [[Baltimore]]/[[Washington, D.C.]], [[Chicago]], [[Pittsburgh]], and [[Los Angeles]]. Participants undergo detailed clinical, immunologic, and virologic evaluations semiannually, including interviews, physical examinations, and laboratory tests. The study has adapted over time to incorporate new [[HIV testing]] technologies and treatments, allowing it to provide valuable insights into the changing dynamics of the HIV/AIDS epidemic.

==Findings and Impact==
The MACS has generated a wealth of data that has led to over 1,000 scientific publications. Key findings from the study include:
* The identification of early markers of HIV infection and predictors of disease progression.
* The impact of antiretroviral therapy (ART) on the natural history of HIV, including the benefits of early treatment initiation.
* Insights into the epidemiology of co-infections and co-morbidities in HIV-infected individuals, such as [[hepatitis C]] and [[cardiovascular disease]].
* The effects of behavioral and psychosocial factors on HIV transmission and disease progression.

These findings have helped shape HIV treatment guidelines and prevention strategies, significantly contributing to the reduction in HIV/AIDS-related morbidity and mortality.

==Current Research and Future Directions==
The MACS continues to evolve, focusing on current issues in HIV/AIDS research, including the long-term effects of ART, aging with HIV, and the potential for HIV eradication. The study is also exploring the implications of co-morbid conditions that are increasingly relevant as the HIV-infected population ages.

==Conclusion==
The Multicenter AIDS Cohort Study has played a pivotal role in understanding HIV/AIDS. Its comprehensive data collection and long-term follow-up of participants have provided invaluable insights into the disease's natural history, treatment, and prevention. As the epidemic continues to evolve, the MACS remains a critical resource for addressing new challenges in HIV/AIDS research and care.

[[Category:HIV/AIDS]]
[[Category:Clinical Research]]
[[Category:Epidemiology]]

{{medicine-stub}}

Multicenter AIDS Cohort Study - Revision history

Prab: CSV import

Prab: CSV import

Prab: CSV import